PF

Paul R. Fatheree

TI Theravance Biopharma R&D Ip: 5 patents #2 of 51Top 4%
📍 San Francisco, CA: #294 of 6,446 inventorsTop 5%
🗺 California: #3,228 of 67,890 inventorsTop 5%
Overall (2019): #22,672 of 560,194Top 5%
6
Patents 2019

Issued Patents 2019

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10519153 Fused imidazo-piperidine JAK inhibitors Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden, Melanie A. Kleinschek +1 more 2019-12-31
10493077 Fused imidazo-piperidine JAK inhibitor compound Lan Jiang, Venkat R. Thalladi, Marta Dabros, Jerry Nzerem 2019-12-03
10392386 JAK inhibitors containing a 4-membered heterocyclic amide Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden, Melanie A. Kleinschek +1 more 2019-08-27
10308617 Triazole benzamide derivatives and the compositions and methods of treatment regarding the same Jennifer Johnston, Albert W. Garofalo 2019-06-04
10208040 Fused imidazo-piperidine JAK inhibitors Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden, Melanie A. Kleinschek +1 more 2019-02-19
10196393 JAK inhibitors containing a 4-membered heterocyclic amide Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2019-02-05